#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4832093	F	Antiproliferative activity against human K562 cells assessed as cell growth inhibition measured after 48 hrs by CCK8 assay	Homo sapiens	24		cell-based format	Scientific Literature
2.	ALA4832094	B	PROTAC activity at CRBN/Bcr-Abl in human K562 cells assessed as degrading activity by Western blotting analysis	Homo sapiens	24		cell-based format	Scientific Literature
3.	ALA4832095	A	Half life in Wistar rat at 2 mg/kg, iv by LC-MS/MS analysis	Rattus norvegicus	3		organism-based format	Scientific Literature
4.	ALA4832096	A	Tmax in Wistar rat at 2 mg/kg, iv by LC-MS/MS analysis	Rattus norvegicus	3		organism-based format	Scientific Literature
5.	ALA4832097	A	Cmax in Wistar rat at 2 mg/kg, iv by LC-MS/MS analysis	Rattus norvegicus	3		organism-based format	Scientific Literature
6.	ALA4832098	A	AUC (0 to t) in Wistar rat at 2 mg/kg, iv by LC-MS/MS analysis	Rattus norvegicus	3		organism-based format	Scientific Literature
7.	ALA4832099	A	MRT (0 to t) in Wistar rat at 2 mg/kg, iv by LC-MS/MS analysis	Rattus norvegicus	3		organism-based format	Scientific Literature
8.	ALA4832100	A	Apparent volume of distribution during steady state in Wistar rat at 2 mg/kg, iv by LC-MS/MS analysis	Rattus norvegicus	3		organism-based format	Scientific Literature
9.	ALA4832101	A	Apparent volume of distribution during terminal state in Wistar rat at 2 mg/kg, iv by LC-MS/MS analysis	Rattus norvegicus	3		organism-based format	Scientific Literature
10.	ALA4832102	A	Clearance in Wistar rat at 2 mg/kg, iv by LC-MS/MS analysis	Rattus norvegicus	3		organism-based format	Scientific Literature
11.	ALA4832103	B	PROTAC activity at CRBN/Bcr-Abl in human K562 cells assessed as reduction in Bcr-Abl level after 16 hrs by Western blotting analysis	Homo sapiens	2		cell-based format	Scientific Literature
12.	ALA4832104	B	PROTAC activity at CRBN/Bcr-Abl in human K562 cells assessed as reduction in c-Abl level after 16 hrs by Western blotting analysis	Homo sapiens	2		cell-based format	Scientific Literature
13.	ALA4832105	B	PROTAC activity at CRBN/Bcr-Abl in human K562 cells assessed as reduction in STAT5 level after 16 hrs by Western blotting analysis	Homo sapiens	1		cell-based format	Scientific Literature
14.	ALA4832106	B	PROTAC activity at CRBN/Bcr-Abl in human K562 cells assessed as reduction in CRLK level after 16 hrs by Western blotting analysis	Homo sapiens	1		cell-based format	Scientific Literature
15.	ALA4832107	B	PROTAC activity at CRBN/Bcr-Abl in human K562 cells assessed as reduction in Bcr-Abl level at 30 nM by Western blotting analysis	Homo sapiens	1		cell-based format	Scientific Literature
16.	ALA4832108	B	PROTAC activity at CRBN/Bcr-Abl in human K562 cells assessed as reduction in Bcr-Abl level at 30 nM preincubated with proteasome inhibitor MG132 for 2 hrs and measured after 8 hrs by Western blotting analysis	Homo sapiens	1		cell-based format	Scientific Literature
17.	ALA4832109	B	PROTAC activity at CRBN/Bcr-Abl in human K562 cells assessed as reduction in C-Abl level at 30 nM preincubated with proteasome inhibitor MG132 for 2 hrs and measured after 8 hrs by Western blotting analysis	Homo sapiens	1		cell-based format	Scientific Literature
18.	ALA4832110	B	PROTAC activity at CRBN/Bcr-Abl in human K562 cells assessed as reduction in Bcr-Abl level at 30 nM preincubated with NEDD8 inhibitor MLN4924 for 2 hrs and measured after 8 hrs by Western blotting analysis	Homo sapiens	1		cell-based format	Scientific Literature
19.	ALA4832111	B	PROTAC activity at CRBN/Bcr-Abl in human K562 cells assessed as reduction in C-Abl level at 30 nM preincubated with NEDD8 inhibitor MLN4924 for 2 hrs and measured after 8 hrs by Western blotting analysis	Homo sapiens	1		cell-based format	Scientific Literature
20.	ALA4832112	B	PROTAC activity at CRBN/BCR-ABL G250E mutant in human K562 cells assessed as degradation by Western blot analysis relative to control	Homo sapiens	1		cell-based format	Scientific Literature